AMERICAN UNIVERSITY | WASHINGTON COLLEGE OF LAW

Health Law & Policy Brief

The Health Law & Policy Brief is an online publication run by law students at American University Washington College of Law. Founded in 2007, the Health Law & Policy Brief publishes articles on a wide array of cutting-edge topics in health law. Such topics include health care compliance, fraud and abuse enforcement, health insurance payment and reimbursement issues, intellectual property issues, international human rights issues, FDA initiatives and policies, and a host of other matters. Beginning with a staff of just five, the Health Law & Policy Brief now boasts over twenty members and nearly 1,500 readers.


Latest from the Blog

dummy-img

The Future of Litigating Fraudulent Medicare Claims

Veronica WalshApr 16, 2023
The False Claims Act (“FCA”), which is mainly used to litigate fraudulent Medicare claims, is being challenged in the Supreme Court. In U.S. ex. Rel. Polansky v. Executive Health Resources, Inc., Polansky argues that in granting the Department of Justice (“DOJ”) the ability to move to dismiss the realtor’s FCA […]
dummy-img

The Implications of Data-Sharing Skepticism in Healthcare

Hallie HoffmannApr 16, 2023
There may be no stranger with whom the average person shares more private details of their life with than their doctor. The primary healthcare mechanism to protect patient privacy in healthcare, the Health Insurance Portability and Accountability Act (“HIPAA”) was passed in 1996, but was, as its title suggests, heavily […]
dummy-img

Telehealth or Telefraud? The Rise yet Continued Short-Comings of Telehealth Post-Pandemic.

Seth BilbreyApr 16, 2023
Although the word telehealth is new in most of our vocabularies, the idea itself is not. As early as 1925, doctors were diagnosing patients over the radio, and in 1959 patients and physicians were using video telecommunications to connect with one another.  Telehealth now, however, is booming. In the year […]
dummy-img

Ozempic: The New Miracle Weight Loss Drug?

Ozempic is an antidiabetic medication developed by Novo Nordisk in 2012 and the United States Food and Drug Administration (FDA) first approved the medication in 2017. Used for the treatment of type 2 diabetes, Ozempic is designed to be injected once a week in the stomach, thigh, or arm. In […]
dummy-img

Cancer in America: History, Progress, and Challenges Ahead

Guy CheathamMar 19, 2023
“Its palliation is a daily task, its cure is a fervent hope.”- William Castle, describing leukemia in 1950. In The Histories, Herodotus records the story of Queen Atoosa of Persia (Atoosa), specifically the unusual illness that struck her in the form of a bleeding lump in her breast rising from […]